Daniel Schneeberger
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel Schneeberger
Earlier roles on record: CEO at Anebulo Pharmaceuticals, Inc. (ANEB) until February 1, 2022. The proxy statement of Anebulo Pharmaceuticals, Inc. reports total compensation of $8,797 for Daniel Schneeberger in fiscal 2022, including a base salary of $8,797. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-02-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Anebulo Pharmaceuticals, Inc. (ANEB) | Former President and Chief Executive Officer | $8,797 | $8,797 |
| 2021 | Anebulo Pharmaceuticals, Inc. (ANEB) | Former President and Chief Executive Officer | $13,978 | $120,416 |
Recent activity
No call appearances or filed executive changes recorded yet.